Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

NCT04775745

Conditions: Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
Locations: Duke Univerisity Durham, North Carolina, United States

University of Cincinnati Cincinnati, Ohio, United States

Ohio State University Columbus, Ohio, United States

Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

NCT07333261

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

NCT07071051

Conditions: Childhood Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma, Hematologic Diseases, +10 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

NCT06191887

Conditions: B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions: ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations: Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States

Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States

Napa Research Pompano Beach, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 36 locations

View Trial Details

Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

NCT05079282

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

University of California Irvine Medical Center - Chao Family Comprehensive Cancer Center Orange, California, United States

Stanford Cancer Institute Palo Alto, California, United States

View all 20 locations

View Trial Details

Recruiting

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

NCT06099912

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Frailty, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Recruiting

Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)

NCT06517511

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

National Longitudinal Cohort of Hematological Diseases

NCT04645199

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Aplastic, +53 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

NCT06710418

Conditions: Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, +25 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions